Financial Comparison: Sanara MedTech (NASDAQ:SMTI) vs. Jin Medical International (NASDAQ:ZJYL)

Sanara MedTech (NASDAQ:SMTIGet Free Report) and Jin Medical International (NASDAQ:ZJYLGet Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, profitability, valuation and earnings.

Insider and Institutional Ownership

8.1% of Sanara MedTech shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk & Volatility

Sanara MedTech has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, Jin Medical International has a beta of 15.69, indicating that its share price is 1,469% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Sanara MedTech and Jin Medical International, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanara MedTech 0 0 1 0 3.00
Jin Medical International 0 0 0 0 N/A

Sanara MedTech presently has a consensus price target of $44.00, suggesting a potential upside of 59.30%. Given Sanara MedTech’s higher probable upside, analysts clearly believe Sanara MedTech is more favorable than Jin Medical International.

Valuation and Earnings

This table compares Sanara MedTech and Jin Medical International’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sanara MedTech $64.99 million 3.67 -$4.30 million ($0.59) -46.81
Jin Medical International N/A N/A N/A N/A N/A

Jin Medical International has lower revenue, but higher earnings than Sanara MedTech.

Profitability

This table compares Sanara MedTech and Jin Medical International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sanara MedTech -7.19% -11.33% -7.02%
Jin Medical International N/A N/A N/A

Summary

Sanara MedTech beats Jin Medical International on 5 of the 9 factors compared between the two stocks.

About Sanara MedTech

(Get Free Report)

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

About Jin Medical International

(Get Free Report)

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

Receive News & Ratings for Sanara MedTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanara MedTech and related companies with MarketBeat.com's FREE daily email newsletter.